|
Induction chemotherapy with nanosomal docetaxel lipid suspension (NDLS), cisplatin, and fluorouracil in patients with locally advanced head and neck squamous cell carcinoma. |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Employment - Jina Pharmaceuticals |
| |
|
Employment - Jina Pharmaceuticals |
| |
|
Employment - Jina Pharmaceuticals |
| |
|
|
| |
|
No Relationships to Disclose |
| |
|
|
| |
|
|
| |
|
|
| |
|
Employment - Jina Pharmaceuticals |